Tapewire

NYSE · USD

EW

Edwards Lifesciences Corp

Export transactions ↓
Tapewire entity
3026
SEC CIK
0001099800
Parsed reports
947

Last 12 months

Inside the activity.

0 purchase rows · 54 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 2025010
Jan 202603
Feb 202603
Mar 202604
Apr 202605
May 2026012
Jun 202602
Jul 202604
Aug 202606
Sep 202601
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 20, 2021 Filed Dec 21, 2021 02:34 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
GiftCommon Stock 12,500 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-015166 · doc4.xml · nonDerivative · entry 6

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Living Trust

Disclosed balance after: 3,235,287

Read SEC document
December 20, 2021 Filed Dec 21, 2021 02:34 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 13,215 $119.37 $1,577,474.55
Disclosure

SEC source: 0001225208-21-015166 · doc4.xml · nonDerivative · entry 5

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,001.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.

F4 · price: This transaction was executed in multiple trades at prices ranging from $118.8850 to $119.8550. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 20, 2021 Filed Dec 21, 2021 02:34 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 12,809 $118.37 $1,516,201.33
Disclosure

SEC source: 0001225208-21-015166 · doc4.xml · nonDerivative · entry 4

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,216.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $117.8700 to $118.8700. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 20, 2021 Filed Dec 21, 2021 02:34 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
GiftCommon Stock 12,500 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-015166 · doc4.xml · nonDerivative · entry 3

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 214,025.82

Read SEC document
December 20, 2021 Filed Dec 21, 2021 02:34 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 6,526 $120.09 $783,707.34
Disclosure

SEC source: 0001225208-21-015166 · doc4.xml · nonDerivative · entry 2

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 226,525.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $119.8900 to $120.8200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 20, 2021 Filed Dec 21, 2021 02:34 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionCommon Stock 45,050 $21.76 $980,288.00
Disclosure

SEC source: 0001225208-21-015166 · doc4.xml · nonDerivative · entry 1

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 233,051.82

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.

Read SEC document
December 17, 2021 Filed Dec 18, 2021 00:51 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 10,000 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-21-015136 · doc4.xml · derivative · entry 3

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,400

Underlying: Common Stock · 10,000 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 17, 2021 Filed Dec 18, 2021 00:51 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 10,000 $121.24 $1,212,400.00
Disclosure

SEC source: 0001225208-21-015136 · doc4.xml · nonDerivative · entry 2

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,414.5223

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021.

Read SEC document
December 17, 2021 Filed Dec 18, 2021 00:51 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionCommon Stock 10,000 $21.76 $217,600.00
Disclosure

SEC source: 0001225208-21-015136 · doc4.xml · nonDerivative · entry 1

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,414.5223

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021.

Read SEC document
December 10, 2021 Filed Dec 11, 2021 01:41 UTC
Wood Larry LCVP, TAVR
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 7,830 $0.00 Strike: $35.20 $0.00
Disclosure

SEC source: 0001225208-21-014811 · doc4.xml · derivative · entry 4

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,830 shares

Expires 2023-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 10, 2021 Filed Dec 11, 2021 01:41 UTC
Wood Larry LCVP, TAVR
SaleCommon Stock 7,830 $121.49 $951,266.70
Disclosure

SEC source: 0001225208-21-014811 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,432.42

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021.

Read SEC document
December 10, 2021 Filed Dec 11, 2021 01:41 UTC
Wood Larry LCVP, TAVR
Exercise / conversionCommon Stock 7,830 $35.20 $275,590.16
Disclosure

SEC source: 0001225208-21-014811 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,262.42

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021.

F2 · balance_after: Represents shares transferred to the reporting person's ex-spouse pursuant to a divorce judgement. The securities owned by the ex-spouse are not beneficially owned by the reporting person.

Read SEC document
December 10, 2021 Filed Dec 11, 2021 01:36 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 11,050 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-21-014810 · doc4.xml · derivative · entry 6

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,200

Underlying: Common Stock · 11,050 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 10, 2021 Filed Dec 11, 2021 01:36 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 10,240 $121.46 $1,243,791.36
Disclosure

SEC source: 0001225208-21-014810 · doc4.xml · nonDerivative · entry 3

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,399.3995

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $120.9100 to $121.9500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 10, 2021 Filed Dec 11, 2021 01:36 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 810 $122.04 $98,855.07
Disclosure

SEC source: 0001225208-21-014810 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,639.3995

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $122.0050 to $122.0700. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 10, 2021 Filed Dec 11, 2021 01:36 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionCommon Stock 11,050 $21.76 $240,448.00
Disclosure

SEC source: 0001225208-21-014810 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,449.3995

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

Read SEC document
December 10, 2021 Filed Dec 11, 2021 01:27 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 6,350 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-21-014809 · doc4.xml · derivative · entry 4

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,700

Underlying: Common Stock · 6,350 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 10, 2021 Filed Dec 11, 2021 01:27 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 5,950 $121.46 $722,701.88
Disclosure

SEC source: 0001225208-21-014809 · doc4.xml · nonDerivative · entry 3

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,026.8935

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $121.01 to $121.88. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 10, 2021 Filed Dec 11, 2021 01:27 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 400 $122.04 $48,817.00
Disclosure

SEC source: 0001225208-21-014809 · doc4.xml · nonDerivative · entry 2

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,976.8935

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $122.01 to $122.09. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 10, 2021 Filed Dec 11, 2021 01:27 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionCommon Stock 6,350 $21.76 $138,176.00
Disclosure

SEC source: 0001225208-21-014809 · doc4.xml · nonDerivative · entry 1

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,376.8935

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021.

Read SEC document
November 29, 2021 Filed Nov 30, 2021 01:21 UTC
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 100 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-21-014184 · doc4.xml · derivative · entry 3

Lemercier Jean-Luc M · CIK 0001710625 · CVP, EMEA, Canada, Latin Amer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,880

Underlying: Common Stock · 100 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 29, 2021 Filed Nov 30, 2021 01:21 UTC
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer
SaleCommon Stock 100 $110.58 $11,058.00
Disclosure

SEC source: 0001225208-21-014184 · doc4.xml · nonDerivative · entry 2

Lemercier Jean-Luc M · CIK 0001710625 · CVP, EMEA, Canada, Latin Amer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,103.487

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2021.

Read SEC document
November 29, 2021 Filed Nov 30, 2021 01:21 UTC
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer
Exercise / conversionCommon Stock 100 $21.76 $2,176.00
Disclosure

SEC source: 0001225208-21-014184 · doc4.xml · nonDerivative · entry 1

Lemercier Jean-Luc M · CIK 0001710625 · CVP, EMEA, Canada, Latin Amer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,203.487

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2021.

Read SEC document
November 24, 2021 Filed Nov 24, 2021 22:28 UTC PurchaseCommon Stock 1,500 $112.23 $168,345.00
Disclosure

SEC source: 0001225208-21-014149 · doc4.xml · nonDerivative · entry 1

VALERIANI NICHOLAS J · CIK 0001263149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,811

Read SEC document
November 18, 2021 Filed Nov 19, 2021 22:31 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 10,000 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-21-013981 · doc4.xml · derivative · entry 5

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,400

Underlying: Common Stock · 10,000 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 18, 2021 Filed Nov 19, 2021 22:31 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 6,357 $117.88 $749,394.31
Disclosure

SEC source: 0001225208-21-013981 · doc4.xml · nonDerivative · entry 4

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,414.5223

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021.

F4 · price: This transaction was executed in multiple trades at prices ranging from $117.5790 to $118.4800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 18, 2021 Filed Nov 19, 2021 22:31 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 2,390 $116.98 $279,586.26
Disclosure

SEC source: 0001225208-21-013981 · doc4.xml · nonDerivative · entry 3

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,771.5223

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $116.4900 to $117.3600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 18, 2021 Filed Nov 19, 2021 22:31 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 1,253 $118.87 $148,947.12
Disclosure

SEC source: 0001225208-21-013981 · doc4.xml · nonDerivative · entry 2

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,161.5223

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $118.5900 to $118.8800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 18, 2021 Filed Nov 19, 2021 22:31 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionCommon Stock 10,000 $21.76 $217,600.00
Disclosure

SEC source: 0001225208-21-013981 · doc4.xml · nonDerivative · entry 1

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,414.5223

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021.

Read SEC document
November 10, 2021 Filed Nov 10, 2021 22:38 UTC
Wood Larry LCVP, TAVR
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 7,830 $0.00 Strike: $35.20 $0.00
Disclosure

SEC source: 0001225208-21-013769 · doc4.xml · derivative · entry 4

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,830

Underlying: Common Stock · 7,830 shares

Expires 2023-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 10, 2021 Filed Nov 10, 2021 22:38 UTC
Wood Larry LCVP, TAVR
SaleCommon Stock 7,830 $119.79 $937,955.70
Disclosure

SEC source: 0001225208-21-013769 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 372,133.5508

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021.

Read SEC document
November 10, 2021 Filed Nov 10, 2021 22:38 UTC
Wood Larry LCVP, TAVR
Exercise / conversionCommon Stock 7,830 $35.20 $275,590.16
Disclosure

SEC source: 0001225208-21-013769 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 379,963.5508

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021.

Read SEC document
November 09, 2021 Filed Nov 10, 2021 00:45 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 45,050 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-21-013738 · doc4.xml · derivative · entry 7

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,300

Underlying: Common Stock · 45,050 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 09, 2021 Filed Nov 10, 2021 00:45 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
GiftCommon Stock 12,500 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-013738 · doc4.xml · nonDerivative · entry 5

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Living Trust

Disclosed balance after: 3,222,787

Read SEC document
November 09, 2021 Filed Nov 10, 2021 00:45 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 18,428 $119.70 $2,205,831.60
Disclosure

SEC source: 0001225208-21-013738 · doc4.xml · nonDerivative · entry 4

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,001.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $118.9400 to $119.9400. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 09, 2021 Filed Nov 10, 2021 00:45 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 14,122 $120.17 $1,697,040.74
Disclosure

SEC source: 0001225208-21-013738 · doc4.xml · nonDerivative · entry 3

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,429.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $119.9500 to $120.4050. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 09, 2021 Filed Nov 10, 2021 00:45 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
GiftCommon Stock 12,500 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-013738 · doc4.xml · nonDerivative · entry 2

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,551.82

Read SEC document
November 09, 2021 Filed Nov 10, 2021 00:45 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionCommon Stock 45,050 $21.76 $980,288.00
Disclosure

SEC source: 0001225208-21-013738 · doc4.xml · nonDerivative · entry 1

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 233,051.82

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.

Read SEC document
November 08, 2021 Filed Nov 8, 2021 23:10 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 6,350 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-21-013694 · doc4.xml · derivative · entry 3

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,050

Underlying: Common Stock · 6,350 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 08, 2021 Filed Nov 8, 2021 23:10 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 6,350 $119.40 $758,190.00
Disclosure

SEC source: 0001225208-21-013694 · doc4.xml · nonDerivative · entry 2

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,026.8935

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021.

Read SEC document
November 08, 2021 Filed Nov 8, 2021 23:10 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionCommon Stock 6,350 $21.76 $138,176.00
Disclosure

SEC source: 0001225208-21-013694 · doc4.xml · nonDerivative · entry 1

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,376.8935

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021.

Read SEC document
November 05, 2021 Filed Nov 5, 2021 21:31 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 11,050 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-21-013644 · doc4.xml · derivative · entry 6

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,250

Underlying: Common Stock · 11,050 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 05, 2021 Filed Nov 5, 2021 21:31 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 6,459 $116.81 $754,444.14
Disclosure

SEC source: 0001225208-21-013644 · doc4.xml · nonDerivative · entry 3

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,399.3995

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $116.40 to $117.36. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 05, 2021 Filed Nov 5, 2021 21:31 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 4,591 $117.68 $540,263.83
Disclosure

SEC source: 0001225208-21-013644 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,858.3995

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $117.42 to $118.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 05, 2021 Filed Nov 5, 2021 21:31 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionCommon Stock 11,050 $21.76 $240,448.00
Disclosure

SEC source: 0001225208-21-013644 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,449.3995

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.

Read SEC document
October 18, 2021 Filed Oct 18, 2021 21:00 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 9,741 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-21-013132 · doc4.xml · derivative · entry 4

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,400

Underlying: Common Stock · 9,741 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 18, 2021 Filed Oct 18, 2021 21:00 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 7,138 $110.24 $786,883.13
Disclosure

SEC source: 0001225208-21-013132 · doc4.xml · nonDerivative · entry 3

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,414.5223

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $109.6400 to $110.6100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 18, 2021 Filed Oct 18, 2021 21:00 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 2,603 $110.87 $288,598.51
Disclosure

SEC source: 0001225208-21-013132 · doc4.xml · nonDerivative · entry 2

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,552.5223

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $110.6400 to $110.9100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 18, 2021 Filed Oct 18, 2021 21:00 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionCommon Stock 9,741 $21.76 $211,964.16
Disclosure

SEC source: 0001225208-21-013132 · doc4.xml · nonDerivative · entry 1

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,155.5223

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021.

Read SEC document
October 11, 2021 Filed Oct 12, 2021 20:51 UTC
Wood Larry LCVP, TAVR
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 7,830 $0.00 Strike: $35.20 $0.00
Disclosure

SEC source: 0001225208-21-013089 · doc4.xml · derivative · entry 4

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,660

Underlying: Common Stock · 7,830 shares

Expires 2023-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.